18-Aug-2021 | Market Research Store
Addison’s Disease Drug Market by Drug Class (Glucocorticoid, Mineralocorticoid, and Others), Route of Administration (Oral, Parenteral, and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026 report states that the global demand for the Addison’s disease drug market in 2020 was approximately USD 980.3 Million. The market is projected to grow at a CAGR of 3.1% and is projected to reach around USD 1,800.9 Million by 2026.
Addison's disease is identified by a rare disorder with deficient production of the steroid hormones that is known as cortisol and aldosterone from the adrenal glands' cells. Indication of Addison’s disease is recognized as the main adrenal deficiency which results in an insufficient amount of production of two hormones i.e. cortisol and aldosterone. Symptoms of Addison’s disease consist of, fatigue, nausea, dizziness, gastrointestinal abnormalities, and changes in skin color. Sometimes mood changes and behavior may occur in patients with Addison's disease. The requirement for treatment of Addison’s disease is rising due to growing incidences of disease, growing profits in developed economies, and growing awareness among patients. Furthermore, expanding health expenses is driving the global market.
Addison’s disease needed long-term cure with steroid substitution treatment. Glucocorticoid and mineral corticoid substitution treatment is now helpful for the cure of Addison’s disease. Moreover, the most chosen drugs called hydrocortisone are associated with the glucocorticoid group owing to its short-lived which enables it to be rapidly occupying within the bloodstream. On a daily basis dosing schedule, extensive acting of glucocorticoids such as prednisone and dexamethasone are useful without replicating the daily rhythm of endogenous cortisol assembly in the body that results in excess glucocorticoid level during the night. Rarely approved fludrocortisone associated with the mineral corticoid group is commonly prescribed alongside hydrocortisone.
The increasing awareness among patients, development, and advancement in the treatments, and occurrence of advanced healthcare organizations are some of the significant factors for the requirement of Addison's disease drugs. Moreover, the rising cases of Addison's disease and the increase in research and development projects managed by various pharmaceutical companies enhance the growth of Addison's disease drug market. Factors such as prominent markets and enormous investment in research and development activities are accountable for the growth of Addison's disease drug market.
Furthermore, the shortage of identification and detection of disorder acts as a restraint to the market in developing countries.
Here, North America is considered as the largest market for Addison’s disease treatment due to high concern for human healthiness and growing awareness among patients. Moreover, the U.S. and Canada have been effectively utilizing the Addison’s disease treatment which is likely to stimulate market growth in the region. The occurrence of well-established health care infrastructures, government initiatives in Addison’s disease treatment is expected to drive the market growth in North America. Europe was the second major market in Addison’s disease treatment due to improvement in health processes and implementation of high health care concerns.
The Asia Pacific is also expected to be the highest growing market in Addison's disease treatment. The large population and growing awareness about health in the regions of India and China are about to boost the Addison’s disease treatment market. Due to the rising medical infrastructure and increasing disposable incomes, the countries like Latin America, Brazil, and Mexico have major potential for the growth of Addison's disease treatment market.
The major key manufacturers in the global Addison’s disease drugs market include Novartis AG, Lupin, Bio-Techne, Merck & Co., Inc, Abbott, Amgen Inc, Biogen, Bayer AG, Pfizer Inc, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Bristol-Myers Squibb Company and others.
For example, Takeda Pharmaceutical Company Limited is the leading pharmaceutical company in Japan and one of the large-scale leaders of the industry. It focuses on the improvement of patients’ health at a global level through their new innovation in medicines. Takeda's ethical drugs are traded in around 100 countries across the globe.
Browse the full “Addison’s Disease Drug Market by Drug Class (Glucocorticoid, Mineralocorticoid, and Others), Route of Administration (Oral, Parenteral, and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026.” Report at https://www.marketresearchstore.com/toc/addisons-disease-drug-market-828617
This report segments the Addison’s disease drug market as follows:
Global Addison’s Disease Drug Market: By Drug
Global Addison’s Disease Drug Market: By Route of Administration
Global Addison’s Disease Drug Market: End-Users
Global Addison’s Disease Drug Market: Distribution Channel
Global Addison’s Disease Drug Market: Regional Segmentation Analysis
About Us:
Market Research Store is a single destination for all types of industries, global, and regional reports. We feature large repository of latest industry reports and market statistics published by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available. Our vast database of reports enables our clients to benefit from expert insights on global industries, products, and market trends.
Contact Us:
Market Research Store
244 Fifth Avenue, Suite N202
New York, 10001, United States
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@MarketResearchStore.com
Website: https://www.marketresearchstore.com